Invictus MD (CSE:IMH, OTC:IVITF) Aquires 150 acres to Increase Production

Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares of a late stage applicant ("OptionCo") from its current shareholders. OptionCo has built 60,000 square feet of secured perimeter for its current production facility located on 150 acres, which is expected to have production capacity of up to 6,000 kg per annum. OptionCo has already submitted plans for additional buildings on the Property including a 30,000 square foot facility.

Alliance Growth Corp. (CSE:AGC) Assembles Top-Teir Growing Team

Alliance Growth Corp. executives announce that the Company has executed the founders agreement with a private Health Canada Licensed Producer Applicant based in Ontario, Canada.

The next step is a $25,000 first payment for the equity investment. The agreement will include long term plantlet supply contract and an off-take agreement at wholesale cost for flower to be used for CBD oil extraction at the Cannabis Botany Centre.

Invictus MD (CSE:IMH, OTC:IVITF) Acquires 150 acres to Increase Production

Invictus MD Strategies Corp. (CSE:IMH, OTC:IVITF) is pleased to announce that on February 6, 2017 it has acquired 100% of the outstanding shares from its current shareholders.

They have acquired 60,000 square feet of secured perimeter for its current production facility located on 150 acres. They have already submitted plans for additional buildings on the Property including a 30,000 square foot facility.

Crown Baus (OTC:CBCA) to Spend Upwards of $6m on Greenhouse Space

Crown Baus Capital Corp. (OTC:CBCA) is negotiating investment opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada.

Phase 1 for each one acre build-out will cost approximately $300,000 to $500,000 USD with full production capacity maxing out at approximately 33,000 sq. ft.

GW Pharma Looks Better Than Ever to Investors

The world’s largest company involved with producing therapeutics derived from cannabis posted a fiscal first-quarter loss of $19.25 million.

GW Pharmaceuticals (NASDAQ:GWPH) said it lost $0.768 per American depository share (ADS) in its fiscal first quarter, well below analysts’ consensus estimate of $1.20. Each ADS represents 12 ordinary shares.

#Cannabis #Stock News: Tetra Bio-Pharma Inc. (CSE:TBP) (CSE:TBP.CN) Enters into Distribution and Supply Agreement with Engen Medical Corporation

#Cannabis #Stock News: Tetra Bio-Pharma Inc. (CSE:TBP) (CSE:TBP.CN) Enters into Distribution and Supply Agreement with Engen Medical Corporation

OTTAWA, ONTARIO - February 6, 2017 (Investorideas.com Newswire) Agro-Tek Inc. ("Agro-Tek") a subsidiary of Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain and other medical conditions announced today it has entered into an five (5) year exclusive Supply and Distribution agreement with Engen Medical Corporation ("Engen") for the Canadian distribution of its Munchies B Gone gum ...

Tetra Bio-Pharma Inc. (CSE:TBP) (CSE:TBP.CN) Enters into Distribution and Supply Agreement with Engen Medical Corporation

Agro-Tek Inc. a subsidiary of Tetra Bio-Pharma Inc. (CSE:TBP)(CSE:TBP.CN)(OTC PINK:GRPOF), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain and other medical conditions announced today it has entered into an five (5) year exclusive Supply and Distribution agreement with Engen Medical Corporation for the Canadian distribution of its Munchies B Gone gum.

Aphria (TSXV:APH) Graduates to the TSX

Aphria (TSXV:APH, OTC:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange to graduate from the TSX Venture Exchange and list its common shares on the TSX.

QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

By: Filing Services Canada via Filing Services Canada February 06, 2017 at 17:20 PM EST QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company. QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

QuikFlo (TSXV:QF) Moves into the US Marketplace

QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

The acquisitions include a 12,000 sq. ft. licensed medical marijuana cultivation/production facility and packaging center with over $1 million in medicinal sales in its first year of operation.  The second acquisition is of a start-up company that develops and markets hemp based and CBD infused products for sales nationwide. 

QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.

By: Filing Services Canada via Filing Services Canada February 06, 2017 at 17:20 PM EST QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company. QuikFlo Moves into the US Marijuana Space with Letter of Intent to Acquire Licensed Nevada Production Facility in Addition to a CBD Infused Product Company.